Trade Summary

2 days ago, Grossman Jerrold B, serving as Dir at Adma Biologics, Inc. (ADMA), purchased 12,500 shares at $8.01 per share, for a total transaction value of $100,125.00. Following this transaction, Grossman Jerrold B now holds 594,091 shares of ADMA.

This purchase represents a 2.00% increase in Grossman Jerrold B's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 12, 2026, 1 day after the trade was made.

Adma Biologics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.